LDS/Medical Tests/Platelet Antibodies, Serum

Platelet Antibodies, Serum

Patients who have been diagnosed with thrombocytopenia (low platelets) may be tested for platelet antibodies. Platelet antibodies detected in a patient’s serum indicate either an allo- or autoimmune reaction in which the antibodies target certain antigens on the platelet's surface leading to platelet destruction. It is unknown why the body sees the platelets as foreign and produces antibodies against them. There are various types of platelet antibodies including antibodies against platelet glycoprotein (GP) IIb-IIIa and/or Ib and antibodies against human platelet antigen (HPA-1a). Idiopathic thrombocytopenic purpura (ITP), which causes severe thrombocytopenia, is the most common disorder associated with platelet autoantibodies.

Antibodies to platelet glycoprotein IIb-IIIa or Ib are seen in the majority of ITP patients and symptoms include bleeding under the skin (purpura) and/or mucosal bleeding. Many patients produce multiple antibodies, and once produced, the antibody can bind to the platelets leading to direct destruction by complement-mediated lysis or phagocytosis in the spleen. Neonatal alloimmune thrombocytopenic purpura (NATP) and posttransfusion purpura (PTP) are also diseases caused by platelet antibodies. Antibodies to the human platelet antigen (HPA-1a) are usually seen in these diseases. NATP is caused by maternal antibodies directed against the antigens on the fetal platelets; the maternal antibody crosses the placenta and destroys fetal platelets. PTP occurs when a patient develops an antibody to transfused platelets. Intravenous immunoglobulin given to the patient usually decreases symptoms and fatality due to NATP and PTP.

  • Diagnosis of idiopathic thrombocytopenic purpura (ITP)
  • As an aid in diagnosis of autoimmune thrombocytopenia
  • As an aid in diagnosis of neonatal alloimmune thrombocytopenic purpura
  • As an aid in diagnosis of posttransfusion purpura
  • As an aid in diagnosis of HLA alloantibodies that are associated with refractoriness to platelet transfusions

Positive in:

  • Chronic idiopathic thrombocytopenic purpura
  • Autoimmune thrombocytopenia
  • Neonatal alloimmune thrombocytopenic purpura
  • Posttransfusion purpura
  • Platelet transfusion refractoriness due to HLA antibodies

Note: Testing serum/plasma for NATP should be performed using a maternal sample.

Negative (Non-reactive)
 

 

 

Radiolabeled Antibodies, ELISA, Antigen Capture Immunoassays, Flow Cytometry, ELISA, Platelet Immunofluorescence test.

Serum (SST), whole Blood EDTA (Lavender).

Stability

  • Ambient: 1-3 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Heparin-Induced Thrombocytopenia Antibodies, Platelet Count, Transfusion Reaction Workup, Drug levels of Quinidine, Quinine, Sulfonamides, Sulfonylureas, and/or Salicylates, CBC, Coagulation Studies, Platelet Function Testing, Platelet glycoprotein polymorphism by PCR.

3-7 days.

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Br J Haematol. 2003;120:574. [PMID: 12588344]
  • Blood. 2004;103:4562. [PMID: 14976036]
  • Haematologica. 2005;90:247. [PMID: 15710579]
  • J Thromb Haemost.2005;3:74. [PMID: 15634268]
  • Jacobs DS and DeMott WR. Laboratory Test Handbook 5th. Hudson, OH. Lexi-Comp, Inc (2001).
  • George Fritsma KD. Hematology, Clinical Principles and Applications 3rd Edition. St. Louis: Saunders Elsevier (2007).
  • Revision 2008: Sean C. Blackwell, MD, Autoimmune Disorders in Pregnancy. Retrieved October 9, 2010, from Merck Manuals Online Library: www.merck.com